Resource Type

Journal Article 5

Year

2023 5

Keywords

SARS-CoV-2 3

COVID-19 2

B cell response 1

COVID-19 convalescent 1

Omicron 1

bronchoalveolar lavage fluid (BALF) 1

genomic epidemiology 1

host response 1

inactivated vaccination 1

neutralizing antibody 1

variant 1

open ︾

Search scope:

排序: Display mode:

Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter

Frontiers of Medicine 2023, Volume 17, Issue 4,   Pages 758-767 doi: 10.1007/s11684-022-0981-7

Abstract: diagnosed COVID-19 patients in Shanghai, identifying a large number of sublineages of the SARS-CoV-2 Omicronanalysis, coupled with contact history tracing, revealed simultaneous community transmission of two Omicron

Keywords: SARS-CoV-2     COVID-19     Omicron     genomic epidemiology    

Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant

Frontiers of Medicine 2023, Volume 17, Issue 3,   Pages 576-580 doi: 10.1007/s11684-023-0991-0

Abstract: Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant

Keywords: variant    

extra-large Fangcang hospitals: experience and lessons from containing the highly contagious SARS-CoV-2 Omicron

Frontiers of Medicine 2023, Volume 17, Issue 1,   Pages 165-171 doi: 10.1007/s11684-022-0961-y

Abstract: . {{custom_ra.content}} . . . {{article.highlightEn}} . . . {{article.abstractEn}} . . . {{article.authorSummayEn}} . . . . .

Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination

Frontiers of Medicine 2023, Volume 17, Issue 4,   Pages 747-757 doi: 10.1007/s11684-022-0954-x

Abstract: decreased by 3.3, 1.9, and 2.3 folds relative to the wild-type virus, respectively, and those against the Omicron

Keywords: COVID-19 convalescent     SARS-CoV-2     inactivated vaccination     neutralizing antibody     B cell response    

Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak

Frontiers of Medicine 2023, Volume 17, Issue 3,   Pages 562-575 doi: 10.1007/s11684-022-0977-3

Abstract: The Omicron family of SARS-CoV-2 variants are currently driving the COVID-19 pandemic.Here we analyzed the clinical laboratory test results of 9911 Omicron BA.2.2 sublineages-infected symptomaticTogether, our study delineates the pathophysiological features of Omicron BA.2.2 sublineages and demonstrates

Keywords: SARS-CoV-2     COVID-19     host response     bronchoalveolar lavage fluid (BALF)    

Title Author Date Type Operation

Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter

Journal Article

Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant

Journal Article

extra-large Fangcang hospitals: experience and lessons from containing the highly contagious SARS-CoV-2 Omicron

Journal Article

Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination

Journal Article

Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak

Journal Article